Clinical Trial Update: Universal CAR-T Cells Targeting Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for universal CAR-T cells targeting multiple myeloma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Universal CAR-T cells (multiple myeloma) (CAR-T cell therapy)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Multiple Myeloma in Remission | Phase 1 | Status: RECRUITING